Olema Pharmaceuticals (OLMA) Change in Acquisitions & Divestments (2021 - 2026)

Olema Pharmaceuticals (OLMA) has 6 years of Change in Acquisitions & Divestments data on record, last reported at $74.5 million in Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 23.83% to $74.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $321.7 million, a 6.29% decrease, with the full-year FY2025 number at $345.0 million, up 14.38% from a year prior.
  • Change in Acquisitions & Divestments reached $74.5 million in Q1 2026 per OLMA's latest filing, down from $91.2 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for OLMA hit a ceiling of $148.8 million in Q1 2022 and a floor of $38.8 million in Q3 2022.
  • A 5-year average of $75.1 million and a median of $70.5 million in 2023 define the central range for Change in Acquisitions & Divestments.
  • On a YoY basis, Change in Acquisitions & Divestments climbed as much as 14775.0% in 2022 and fell as far as 67.56% in 2022.
  • Tracing OLMA's Change in Acquisitions & Divestments over 5 years: stood at $61.0 million in 2022, then decreased by 11.48% to $54.0 million in 2023, then skyrocketed by 38.53% to $74.8 million in 2024, then grew by 21.87% to $91.2 million in 2025, then fell by 18.32% to $74.5 million in 2026.
  • Business Quant data shows Change in Acquisitions & Divestments for OLMA at $74.5 million in Q1 2026, $91.2 million in Q4 2025, and $88.9 million in Q3 2025.